FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1823960060> ?p ?o ?g. }

• W1823960060 abstract "Background Traditionally inhaled treatment for asthma has been considered as preventer and reliever therapy. The combination of formoterol and budesonide in a single inhaler introduces the possibility of using a single inhaler for both prevention and relief of symptoms (single inhaler therapy). Objectives The aim of this review is to compare formoterol and corticosteroid in single inhaler for maintenance and relief of symptoms with inhaled corticosteroids for maintenance and a separate reliever inhaler. Search methods We last searched the Cochrane Airways Group trials register in September 2008. Selection criteria Randomised controlled trials in adults and children with chronic asthma. Data collection and analysis Two review authors independently assessed studies for inclusion and extracted the characteristics and results of each study. Authors or manufacturers were asked to supply unpublished data in relation to primary outcomes. Main results Five studies on 5,378 adults compared single inhaler therapy with current best practice, and did not show a significant reduction in participants with exacerbations causing hospitalisation (Peto OR 0.59; 95% CI 0.24 to 1.45) or treated with oral steroids (OR 0.83; 95% CI 0.66 to 1.03). Three of these studies on 4281 adults did not show a significant reduction in time to first severe exacerbation needing medical intervention (HR 0.96; 95% CI 0.85 to 1.07). These trials demonstrated a reduction in the mean total daily dose of inhaled corticosteroids with single inhaler therapy (mean reduction ranged from 107 to 267 micrograms/day, but the trial results were not combined due to heterogeneity). The full results from four further studies on 4,600 adults comparing single inhaler therapy with current best practice are awaited. Three studies including 4,209 adults compared single inhaler therapy with higher dose budesonide maintenance and terbutaline for symptom relief. No significant reduction was found with single inhaler therapy in the risk of patients suffering an asthma exacerbation leading to hospitalisation (Peto OR 0.56; 95% CI 0.28 to 1.09), but fewer patients on single inhaler therapy needed a course of oral corticosteroids (OR 0.54; 95% CI 0.45 to 0.64). These results translate into an eleven month number needed to treat of 14 (95% CI 12 to 18), to prevent one patient being treated with oral corticosteroids for an exacerbation. The run‐in for these studies involved withdrawal of long‐acting beta2‐agonists, and patients were recruited who were symptomatic during run‐in. One study included children (N = 224), in which single inhaler therapy was compared to higher dose budesonide. There was a significant reduction in participants who needed an increase in their inhaled steroids with single inhaler therapy, but there were only two hospitalisations for asthma and no separate data on courses of oral corticosteroids. Less inhaled and oral corticosteroids were used in the single inhaler therapy group and the annual height gain was also 1 cm greater in the single inhaler therapy group, [95% CI 0.3 to 1.7 cm]. There was no significant difference found in fatal or non‐fatal serious adverse events for any of the comparisons. Authors' conclusions Single inhaler therapy can reduce the risk of asthma exacerbations needing oral corticosteroids in comparison with fixed dose maintenance inhaled corticosteroids. Guidelines and common best practice suggest the addition of regular long‐acting beta2‐agonist to inhaled corticosteroids for uncontrolled asthma, and single inhaler therapy has not been demonstrated to significantly reduce exacerbations in comparison with current best practice, although results of five large trials are awaiting full publication. Single inhaler therapy is not currently licensed for children under 18 years of age in the United Kingdom." @default.
• W1823960060 created "2016-06-24" @default.
• W1823960060 creator A5064914332 @default.
• W1823960060 creator A5065716950 @default.
• W1823960060 date "2009-04-15" @default.
• W1823960060 modified "2023-10-15" @default.
• W1823960060 title "Combination formoterol and budesonide as maintenance and reliever therapy versus inhaled steroid maintenance for chronic asthma in adults and children" @default.
• W1823960060 cites W1543855637 @default.
• W1823960060 cites W1598602811 @default.
• W1823960060 cites W1723887941 @default.
• W1823960060 cites W1807048566 @default.
• W1823960060 cites W1983955745 @default.
• W1823960060 cites W1986739600 @default.
• W1823960060 cites W2010176815 @default.
• W1823960060 cites W2012700480 @default.
• W1823960060 cites W2013949673 @default.
• W1823960060 cites W2016541011 @default.
• W1823960060 cites W2025409168 @default.
• W1823960060 cites W2031143026 @default.
• W1823960060 cites W2060492140 @default.
• W1823960060 cites W2079098458 @default.
• W1823960060 cites W2085294706 @default.
• W1823960060 cites W2091408344 @default.
• W1823960060 cites W2099652899 @default.
• W1823960060 cites W2101885173 @default.
• W1823960060 cites W2103872032 @default.
• W1823960060 cites W2107869915 @default.
• W1823960060 cites W2110658984 @default.
• W1823960060 cites W2117904842 @default.
• W1823960060 cites W2125435699 @default.
• W1823960060 cites W2139373697 @default.
• W1823960060 cites W2140596820 @default.
• W1823960060 cites W2141024340 @default.
• W1823960060 cites W2143763881 @default.
• W1823960060 cites W2145352586 @default.
• W1823960060 cites W2147267738 @default.
• W1823960060 cites W2151038720 @default.
• W1823960060 cites W2155834128 @default.
• W1823960060 cites W2157910210 @default.
• W1823960060 cites W2158985275 @default.
• W1823960060 cites W2165209634 @default.
• W1823960060 cites W2167713965 @default.
• W1823960060 cites W4229992274 @default.
• W1823960060 cites W2090177689 @default.
• W1823960060 doi "https://doi.org/10.1002/14651858.cd007313.pub2" @default.
• W1823960060 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4053857" @default.
• W1823960060 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19370682" @default.
• W1823960060 hasPublicationYear "2009" @default.
• W1823960060 type Work @default.
• W1823960060 sameAs 1823960060 @default.
• W1823960060 citedByCount "37" @default.
• W1823960060 countsByYear W18239600602012 @default.
• W1823960060 countsByYear W18239600602013 @default.
• W1823960060 countsByYear W18239600602014 @default.
• W1823960060 countsByYear W18239600602015 @default.
• W1823960060 countsByYear W18239600602016 @default.
• W1823960060 countsByYear W18239600602017 @default.
• W1823960060 countsByYear W18239600602018 @default.
• W1823960060 countsByYear W18239600602019 @default.
• W1823960060 countsByYear W18239600602020 @default.
• W1823960060 countsByYear W18239600602021 @default.
• W1823960060 countsByYear W18239600602022 @default.
• W1823960060 crossrefType "reference-entry" @default.
• W1823960060 hasAuthorship W1823960060A5064914332 @default.
• W1823960060 hasAuthorship W1823960060A5065716950 @default.
• W1823960060 hasBestOaLocation W18239600602 @default.
• W1823960060 hasConcept C126322002 @default.
• W1823960060 hasConcept C2776042228 @default.
• W1823960060 hasConcept C2776136866 @default.
• W1823960060 hasConcept C2776694085 @default.
• W1823960060 hasConcept C2777014857 @default.
• W1823960060 hasConcept C2777419714 @default.
• W1823960060 hasConcept C2777450039 @default.
• W1823960060 hasConcept C2778283404 @default.
• W1823960060 hasConcept C2779871671 @default.
• W1823960060 hasConcept C2780252434 @default.
• W1823960060 hasConcept C2780261241 @default.
• W1823960060 hasConcept C2781018748 @default.
• W1823960060 hasConcept C71924100 @default.
• W1823960060 hasConceptScore W1823960060C126322002 @default.
• W1823960060 hasConceptScore W1823960060C2776042228 @default.
• W1823960060 hasConceptScore W1823960060C2776136866 @default.
• W1823960060 hasConceptScore W1823960060C2776694085 @default.
• W1823960060 hasConceptScore W1823960060C2777014857 @default.
• W1823960060 hasConceptScore W1823960060C2777419714 @default.
• W1823960060 hasConceptScore W1823960060C2777450039 @default.
• W1823960060 hasConceptScore W1823960060C2778283404 @default.
• W1823960060 hasConceptScore W1823960060C2779871671 @default.
• W1823960060 hasConceptScore W1823960060C2780252434 @default.
• W1823960060 hasConceptScore W1823960060C2780261241 @default.
• W1823960060 hasConceptScore W1823960060C2781018748 @default.
• W1823960060 hasConceptScore W1823960060C71924100 @default.
• W1823960060 hasLocation W18239600601 @default.
• W1823960060 hasLocation W18239600602 @default.
• W1823960060 hasLocation W18239600603 @default.
• W1823960060 hasLocation W18239600604 @default.
• W1823960060 hasLocation W18239600605 @default.
• W1823960060 hasOpenAccess W1823960060 @default.
• W1823960060 hasPrimaryLocation W18239600601 @default.
• W1823960060 hasRelatedWork W2019665207 @default.

• next